Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Therapy Name | AFPc332T |
Synonyms | |
Therapy Description |
Limited information is currently available on AFPc332T, putative autologous T-cells expressing AFP-specific T-cell receptors (Aug, 2018). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
AFPc332T | Autologous genetically modified AFPc332T cells | AFPc332T consists of autologous T cells expressing enhanced TCRs specific for alpha-fetoprotein (AFP) (PMID: 30561769). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT03132792 | Phase I | AFPc332T | AFPc332T in Advanced HCC | Recruiting | USA | FRA | ESP | 1 |